首页> 美国卫生研究院文献>Infection and Drug Resistance >Antimicrobial susceptibility profile treatment outcome and serotype distribution of clinical isolates of Salmonella enterica subspecies enterica: a 2-year study from Kerala South India
【2h】

Antimicrobial susceptibility profile treatment outcome and serotype distribution of clinical isolates of Salmonella enterica subspecies enterica: a 2-year study from Kerala South India

机译:肠炎沙门氏菌亚种肠炎亚种临床分离株的抗菌药敏性治疗结果和血清型分布:来自印度南部喀拉拉邦的2年研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background/purposeTyphoid and paratyphoid fever continue to be important causes of illness and death in parts of Asia, being associated with poor sanitation and consumption of unsafe food and water. Antimicrobial resistance has emerged to traditional first-line drugs, namely, the fluoroquinolones, as well as to third-generation cephalosporins, posing challenges to treatment. Azithromycin has proven to be an effective alternative for treatment of uncomplicated typhoid fever. The purpose of this study was to determine the antimicrobial susceptibility, clinical outcome and serotype distribution pattern of clinical isolates belonging to Salmonella enterica subspecies enterica.
机译:背景/目的伤寒和副伤寒仍然是亚洲部分地区疾病和死亡的重要原因,与卫生条件差以及不安全的食物和水的消费有关。传统的一线药物,即氟喹诺酮类药物以及第三代头孢菌素已出现了抗药性,给治疗带来了挑战。阿奇霉素已被证明是治疗单纯性伤寒的有效替代药物。这项研究的目的是确定肠炎沙门氏菌亚种肠炎沙门氏菌临床分离株的抗菌药敏性,临床结局和血清型分布模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号